scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1056/NEJM200006153422407 |
P698 | PubMed publication ID | 10853004 |
P2093 | author name string | Lue TF | |
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1802-1813 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Erectile dysfunction. | |
P478 | volume | 342 |
Q54340037 | A Chinese herbal formula, Shuganyiyang capsule, improves erectile function in male rats by modulating Nos-CGMP mediators. |
Q37165036 | A Quality Analysis of Randomized Controlled Trials about Erectile Dysfunction |
Q80391804 | A Randomised Comparison of the Effects of Nebivolol and Atenolol with and without Chlorthalidone on the Sexual Function of Hypertensive Men |
Q37820206 | A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction |
Q44693716 | A classification based on peak systolic velocity and end diastolic velocity predicts sildenafil citrate success. |
Q35123699 | A discrepancy of penile hemodynamics during visual sexual stimulation observed by near-infrared spectroscopy |
Q35628328 | A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction. |
Q43653615 | A new potential of blood oxygenation level dependent (BOLD) functional MRI for evaluating cerebral centers of penile erection |
Q34129318 | A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy |
Q41945517 | A placebo-controlled, multicenter, randomized, double-blind, flexible-dose, two-way crossover study to evaluate the efficacy and safety of sildenafil in men with traumatic spinal cord injury and erectile dysfunction |
Q97522072 | A prospective study of the effect of antihypertensive medications on the sexual functions of hypertensive adult male patients |
Q24535020 | A role for the melanocortin 4 receptor in sexual function |
Q29387552 | A side effect resource to capture phenotypic effects of drugs |
Q34176644 | A simple and sensitive HPLC fluorescence method for determination of tadalafil in mouse plasma |
Q48049407 | A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction |
Q35105343 | A2B adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation |
Q48327568 | Ac-nle-c[asp-his-dphe-arg-trp-lys]-nh2 induces penile erection via brain and spinal melanocortin receptors |
Q26765211 | Acupuncture for Erectile Dysfunction: A Systematic Review |
Q35277935 | Acupuncture for erectile dysfunction: a systematic review protocol |
Q34005421 | Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism |
Q30234763 | Adipose tissue-derived stem cell therapy for erectile dysfunction in rats: a systematic review and meta-analysis |
Q35750940 | Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction |
Q64060640 | Administration of Adipose Derived Mesenchymal Stem Cells and Platelet Lysate in Erectile Dysfunction: A Single Center Pilot Study |
Q59048530 | Advances in Stem Cell Therapy for Erectile Dysfunction |
Q38966016 | Advances in pharmacotherapy for erectile dysfunction and associated cardiac impact |
Q39327895 | Advances in the understanding of priapism |
Q88945335 | Advantages and limitations of sleep-related erection and rigidity monitoring: a review |
Q36295227 | Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease |
Q46700660 | Altered expression of mitofusin 2 in penile tissues of diabetic rats |
Q46803480 | An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy |
Q28581593 | Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors |
Q34511442 | Andropause: clinical implications of the decline in serum testosterone levels with aging in men. |
Q35648400 | Andropause: endocrinology, erectile dysfunction, and prostate pathophysiology |
Q37972086 | Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED. |
Q40979087 | Aphrodisiac potentials of the ethanol extract of Aloe barbadensis Mill. root in male Wistar rats |
Q54645716 | Application of angiogenic factors for therapy of erectile dysfunction: protein and DNA transfer of VEGF 165 into the rat penis. |
Q36255174 | Assessment, diagnosis, and investigation of erectile dysfunction |
Q44019807 | Associated factors and prevalence of erectile dysfunction in hemodialysis patients |
Q46570966 | Association among metabolic syndrome, testosterone level and severity of erectile dysfunction. |
Q91530137 | Association between chronic obstructive pulmonary disease and risk of erectile dysfunction: a systematic review and meta-analysis |
Q41547928 | Association between coronary heart disease and erectile dysfunction in Chinese Han population |
Q37388112 | Association between erectile dysfunction and coronary artery disease and its severity |
Q34962528 | Association between renal function, erectile function and coronary artery disease: detection with coronary angiography |
Q39871254 | Association of Urinary Phthalate Metabolites With Erectile Dysfunction in Racial and Ethnic Groups in the National Health and Nutrition Examination Survey 2001-2004. |
Q89460098 | Associations between body mass index, waist circumference and erectile dysfunction: a systematic review and META-analysis |
Q56959524 | Author Reply |
Q38846047 | Avanafil - a further step to tailoring patient needs and expectations |
Q38042912 | Avanafil for treatment of erectile dysfunction: review of its potential |
Q34624315 | Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction |
Q44322931 | BAY 41-2272: a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo |
Q51477419 | Beneficial effect of PEDF-transfected ADSCs on erectile dysfunction in a streptozotocin-diabetic rat model. |
Q48626822 | Brain activation and sexual arousal in healthy, heterosexual males |
Q36343594 | Can Erectile Dysfunction in Young Patients Serve as a Surrogate Marker for Coronary Artery Disease? |
Q39775989 | Can simvastatin improve erectile function and health-related quality of life in men aged >40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial [ISRCTN66772971](1). |
Q33506250 | Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men |
Q44919822 | Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5). |
Q24194249 | Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly men |
Q94326362 | Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly men |
Q90737439 | Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis |
Q41949022 | Cell phone usage and erectile function |
Q35949480 | Challenges in the assessment of erectile dysfunction and treatment with oral therapies: review with case examples |
Q63435728 | Characteristics and expectations of patients with erectile dysfunction: results of the SCORED study |
Q45663668 | Characterization of age-related penile microvascular hemodynamic impairment using laser speckle contrast imaging: possible role of increased fibrogenesis |
Q36866586 | Chloroquine-induced nitric oxide as a potential treatment of erectile dysfunction associated with the metabolic syndrome: the science and the fiction |
Q43276188 | Chronic PDE-5 inhibition in patients with erectile dysfunction: new treatment approach using once daily Tadalafil |
Q45926237 | Chronic ethanol consumption induces cavernosal smooth muscle dysfunction in rats. |
Q30241531 | Chronic periodontitis and the risk of erectile dysfunction: a systematic review and meta-analysis |
Q33710353 | Chuanxiongzine relaxes isolated corpus cavernosum strips and raises intracavernous pressure in rabbits |
Q83365363 | Clinical features and treatment options for Chinese patients with severe primary erectile dysfunction |
Q46652301 | Clinical predictive factors of sildenafil response: a penile hemodynamic study |
Q26829068 | Clinical significance of erectile dysfunction developing after acute coronary event: exception to the rule or confirmation of the artery size hypothesis? |
Q26740510 | Clinical use of alprostadil topical cream in patients with erectile dysfunction: a review |
Q50093996 | Coffee intake and incidence of erectile dysfunction |
Q35166471 | Colour Doppler ultrasound of the penis. |
Q51663469 | Combination Therapy Using Human Adipose-derived Stem Cells on the Cavernous Nerve and Low-energy Shockwaves on the Corpus Cavernosum in a Rat Model of Post-prostatectomy Erectile Dysfunction. |
Q90524391 | Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil |
Q34165055 | Combined effects of brain-derived neurotrophic factor immobilized poly-lactic-co-glycolic acid membrane with human adipose-derived stem cells and basic fibroblast growth factor hydrogel on recovery of erectile dysfunction. |
Q42128266 | Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy |
Q54170825 | Combined sildenafil with vacuum erection device therapy in the management of diabetic men with erectile dysfunction after failure of first-line sildenafil monotherapy. |
Q48113809 | Combined therapeutic effect of udenafil and adipose-derived stem cell (ADSC)/brain-derived neurotrophic factor (BDNF)-membrane system in a rat model of cavernous nerve injury |
Q44229954 | Comment: neurologic, psychological, and aggressive disturbances with sildenafil |
Q90318488 | Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials |
Q53248622 | Comparison between subcutaneous injection of basic fibroblast growth factor-hydrogel and intracavernous injection of adipose-derived stem cells in a rat model of cavernous nerve injury. |
Q53126992 | Comparison of efficacy for erectile function and lower urinary tract symptoms of tadalafil 20 mg on-demand and 5 mg once daily in patients with erectile dysfunction. |
Q35201505 | Comparison of the simplified International Index of Erectile Function (IIEF-5) in patients of erectile dysfunction with different pathophysiologies |
Q42186099 | Comprehensive assessment of cavernosography with 320-row dynamic volume CT versus conventional cavernosography in erectile dysfunction patients caused by venous leakage |
Q82596505 | Corpus cavernosum electromyography: could it be a parameter to predict ageing? |
Q53241774 | Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients. |
Q51646688 | Correlation Between the European System for Cardiac Operative Risk Evaluation and Sexual Function After Coronary Artery Bypass Graft Surgery |
Q34161131 | Correlation between penile cavernosal artery blood flow and retinal vascular findings in arteriogenic erectile dysfunction |
Q37393314 | Cross-sectional study of male sexual function in bariatric patients |
Q35384480 | Current Diagnosis and Management of Erectile Dysfunction |
Q47707689 | Current drug use as risk factor for erectile dysfunction: results from an Italian epidemiological study. |
Q50682697 | Cutaneous microcirculatory function predicts the responsiveness to tadalafil in patients with erectile dysfunction and coronary artery disease. |
Q45964628 | Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status. |
Q76321132 | Deep brain stimulation of the thalamus can influence penile erection |
Q47876507 | Delivery of intracavernosal therapies using needle-free injection devices |
Q38253049 | Diagnosing erectile dysfunction could save your patient's life |
Q46571184 | Diagnostic value of nitric oxide, lipoprotein(a), and malondialdehyde levels in the peripheral venous and cavernous blood of diabetics with erectile dysfunction |
Q44057013 | Dietary supplements and other alternative medicines for erectile dysfunction. What do I tell my patients? |
Q45224129 | Difficulties in achieving vs maintaining erection: organic, psychogenic and relational determinants. |
Q35563184 | Disorders of male sexual function |
Q35924360 | Document for the general public. Spanish consensus panel on erectile dysfunction |
Q51367455 | Effect of Ginkgo biloba Extract (EGb-761) on Recovery of Erectile Dysfunction in Bilateral Cavernous Nerve Injury Rat Model. |
Q93081459 | Effect of Nut Consumption on Erectile and Sexual Function in Healthy Males: A Secondary Outcome Analysis of the FERTINUTS Randomized Controlled Trial |
Q35660091 | Effect of an Ethanol Extract of Scutellaria baicalensis on Relaxation in Corpus Cavernosum Smooth Muscle |
Q46495805 | Effect of correcting serum cholesterol levels on erectile function in patients with vasculogenic erectile dysfunction |
Q44362851 | Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction |
Q38744754 | Effect of icariin in combination with daily sildenafil on penile atrophy and erectile dysfunction in a rat model of bilateral cavernous nerves injury |
Q47394896 | Effect of sildenafil citrate on penile weight and physiology of cavernous smooth muscle in a post-radical prostatectomy model of erectile dysfunction in rats. |
Q36247128 | Effect of sildenafil citrate on the cardiovascular system |
Q33378219 | Effect of tadalafil on blood flow, pain, and function in chronic cold complex regional pain syndrome: a randomized controlled trial. |
Q46746720 | Effects of androgen on the expression of vascular endothelial growth factor in the penile corpus cavernosum |
Q64947373 | Effects of combined extracts of Lepidium meyenii and Allium tuberosum Rottl. on erectile dysfunction. |
Q38606909 | Effects of heart rate reduction with ivabradine on the international ındex of erectile function (IIEF-5) in patients with heart failure. |
Q41099902 | Effects of insulin-like growth factor-1 on the relaxation responses of the cavernous smooth muscle from aged rats |
Q36076581 | Effects of male silkworm pupa powder on the erectile dysfunction by chronic ethanol consumption in rats |
Q33890190 | Effects of metformin on endothelial health and erectile dysfunction |
Q43263739 | Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase |
Q33629963 | Effects of the aqueous and hexane extracts of Mondia whitei on the sexual behaviour and some fertility parameters of sexually inexperienced male rats |
Q34139231 | Efficacy and Safety of Tadalafil 5 mg Administered Once Daily in Korean Men with Erectile Dysfunction: A Prospective, Multicenter Study |
Q57059455 | Efficacy and safety of PDE5 inhibitors in the treatment of diabetes mellitus erectile dysfunction: Protocol for a systematic review |
Q91787573 | Efficacy and safety of an herbal formula (KBMSI-2) in the treatment of erectile dysfunction: A preliminary clinical study |
Q38356574 | Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy |
Q44054306 | Efficacy and safety of sildenafil in men with type 2 diabetes mellitus and erectile dysfunction |
Q34231143 | Efficacy and safety of udenafil for erectile dysfunction: a meta-analysis of randomized controlled trials |
Q24236046 | Efficacy and safety of vardenafil in men with diabetes and erectile dysfunction |
Q24240809 | Efficacy and safety of vardenafil in men with diabetes and erectile dysfunction |
Q35580626 | Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction |
Q34163836 | Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA. |
Q35038331 | Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction |
Q46740992 | Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction |
Q57167048 | Efficient Promotion of Autophagy and Angiogenesis Using Mesenchymal Stem Cell Therapy Enhanced by the Low-Energy Shock Waves in the Treatment of Erectile Dysfunction |
Q41891362 | Elective gangrene of the corpus spongiosum of idiopathic origin: A case report |
Q92287415 | Embryonic stem cell-derived extracellular vesicle-mimetic nanovesicles rescue erectile function by enhancing penile neurovascular regeneration in the streptozotocin-induced diabetic mouse |
Q38367700 | Emerging drugs for the treatment of erectile dysfunction |
Q38028739 | Emerging tools for erectile dysfunction: a role for regenerative medicine. |
Q37650850 | Endothelial dysfunction and erectile dysfunction in the aging man. |
Q44085631 | Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation |
Q46175834 | Endovascular therapy for vasculogenic erectile dysfunction |
Q38297294 | Endovascular treatment of vasculogenic erectile dysfunction |
Q24673071 | Enhancement of apomorphine-induced penile erection in the rat by a selective alpha(1D)-adrenoceptor antagonist |
Q43985606 | Epidemiology and pathophysiology of male sexual dysfunction |
Q36314038 | Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors |
Q42805340 | Erectile Dysfunction May Improve by Blood Pressure Control in Patients with High-Risk Hypertension |
Q61454282 | Erectile Dysfunction and Ischaemic Heart Disease |
Q47937519 | Erectile Dysfunction and Sexual Hormone Levels in Men With Obstructive Sleep Apnea: Efficacy of Continuous Positive Airway Pressure |
Q36932529 | Erectile Dysfunction in Male Survivors of Childhood Cancer-A Report From the Childhood Cancer Survivor Study |
Q56966121 | Erectile dysfunction |
Q62029106 | Erectile dysfunction |
Q44739960 | Erectile dysfunction -- still a taboo subject |
Q35130935 | Erectile dysfunction after surgical treatment |
Q36628792 | Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference |
Q37148383 | Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions |
Q35087402 | Erectile dysfunction and diabetes |
Q33710298 | Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors |
Q35977540 | Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment |
Q35068163 | Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator |
Q35572172 | Erectile dysfunction and vascular disease. What is the connection? |
Q37776171 | Erectile dysfunction as a complication of heart failure |
Q37058764 | Erectile dysfunction as a harbinger for increased cardiometabolic risk |
Q36292416 | Erectile dysfunction as a marker for vascular disease |
Q36359841 | Erectile dysfunction as an early sign of cardiovascular disease |
Q33723290 | Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men. |
Q38868978 | Erectile dysfunction in chronic renal failure patients undergoing hemodialysis in Egypt |
Q47549053 | Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension. |
Q53104843 | Erectile dysfunction in myotonic dystrophy type 1 (DM1). |
Q39732313 | Erectile dysfunction in patients with chronic viral liver disease: its relevance to protein malnutrition |
Q36460243 | Erectile dysfunction in patients with liver disease related to chronic hepatitis B |
Q37686844 | Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives. |
Q37109366 | Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial |
Q38846229 | Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments |
Q28709383 | Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study |
Q35720617 | Erectile dysfunction: etiology, evaluation, and treatment options |
Q36016959 | Erectile dysfunction: interrelationship with the metabolic syndrome |
Q35757438 | Erectile dysfunction: management update |
Q35724843 | Erectile dysfunction: symptom or disease? |
Q46437373 | Erectile dysfunction: to prescribe or not to prescribe? |
Q42589268 | Erectile function in two-kidney, one-clip hypertensive rats is maintained by a potential increase in nitric oxide production |
Q45194924 | Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial |
Q50915038 | Erectogenic and Aphrodisiac Property of Moringa oleifera: Involvement of Soluble Epoxide Hydrolase Enzyme. |
Q51250785 | Establishment of in vitro model of erectile dysfunction for the study of high-glucose-induced angiopathy and neuropathy. |
Q35087516 | Etiology and treatment of erectile failure in diabetes mellitus |
Q48526535 | European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted |
Q48525600 | European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constitute |
Q37930859 | Evaluation and treatment of erectile dysfunction in the aging male: a mini-review |
Q91004871 | Evaluation of Sexual Dysfunction, Lower Urinary Tract Symptoms and Quality of Life in Men With Obstructive Sleep Apnea Syndrome and the Efficacy of Continuous Positive Airway Pressure Therapy |
Q53727836 | Evaluation of arterial stiffness and cardiac function in patients with vascular erectile dysfunction: acute effects of phosphodiesterase-5 inhibitor tadalafil. |
Q36020770 | Evaluation of penile perfusion by color-coded duplex sonography in the management of erectile dysfunction |
Q44785618 | Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra |
Q34586101 | Evaluations of erectile dysfunction before and after on-pump coronary artery bypass graft surgery |
Q28566424 | Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function |
Q24655020 | Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling |
Q90259886 | Extracorporeal Shock Waves Therapy Delivered by Aries Improves Erectile Dysfunction in Spontaneously Hypertensive Rats Through Penile Tissue Remodeling and Neovascularization |
Q44764468 | Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan). |
Q39305594 | Fingerroot, Boesenbergia rotunda and its Aphrodisiac Activity |
Q35544101 | From molecules to mammals: what's NOS got to do with it? |
Q35839488 | Future options for combination therapy in the management of erectile dysfunction in older men. |
Q40286700 | Future strategies for treating erectile dysfunction. |
Q36359862 | Gene and stem cell therapy for erectile dysfunction |
Q37775988 | Gene therapy as future treatment of erectile dysfunction |
Q45887184 | Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase |
Q35633865 | Gene therapy treatments for erectile and bladder dysfunction |
Q34707328 | Gene therapy: future therapy for erectile dysfunction |
Q36310656 | Gene transfer for the therapy of erectile dysfunction: progress in the 21st century |
Q57295893 | Genetic variation in the locus is associated with erectile dysfunction |
Q46504484 | Glutathione levels in patients with erectile dysfunction, with or without diabetes mellitus. |
Q37058005 | Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction |
Q46145581 | Has prolactin a role in the hypogonadal status of HIV-infected patients? |
Q33752567 | Hormonal profile, the PROGINS polymorphism, and erectile dysfunction complaints: data from a population-based survey |
Q46055215 | Hot-stage microscopy for determination of API particles in a formulated tablet. |
Q37582767 | How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors |
Q90447541 | Human Tissue Kallikrein 1 Improves Erectile Dysfunction of Streptozotocin-Induced Diabetic Rats by Inhibition of Excessive Oxidative Stress and Activation of the PI3K/AKT/eNOS Pathway |
Q37218153 | Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle. |
Q36292445 | Hypogonadism in the man with erectile dysfunction: what to look for and when to treat |
Q37810422 | Hypogonadism, Erectile Dysfunction, and Type 2 Diabetes Mellitus: What the Clinician Needs to Know |
Q55296399 | Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells. |
Q53215865 | Impact of phosphodiesterase type 5 inhibitors on endothelial function. |
Q36050766 | Impaired erectile function in CD73-deficient mice with reduced endogenous penile adenosine production |
Q37436962 | Impaired flow-mediated vasodilatation in Asian Indians with erectile dysfunction |
Q37221821 | Improvement of erectile dysfunction by the active pepide from Urechis unicinctus by high temperature/pressure and ultra - wave assisted lysis in Streptozotocin Induced Diabetic Rats |
Q37800121 | In Vitro and in Vivo Animal Models in Priapism Research |
Q44085625 | Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users |
Q39732295 | Incidence of erectile dysfunction and characteristics of patients before and after the introduction of sildenafil in the United Kingdom: cross sectional study with comparison patients |
Q45051071 | Increased Risk for Cancer Following Erectile Dysfunction: A Nationwide Population-Based Follow-Up Study |
Q39846013 | Increased Risk of Stroke Among Men with Erectile Dysfunction: A Nationwide Population-Based Study |
Q37085194 | Increased expression of insulin-like growth factor-binding protein-3 is implicated in erectile dysfunction in two-kidney one-clip hypertensive rats after propranolol treatment |
Q37961164 | Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men. |
Q33854121 | Inhibition of Ninjurin 1 restores erectile function through dual angiogenic and neurotrophic effects in the diabetic mouse |
Q48575928 | Insulin resistance is an independent predictor of erectile dysfunction in patients with gout. |
Q44582259 | Internal pudendal artery stenoses and erectile dysfunction: Correlation with angiographic coronary artery disease |
Q46422263 | Interstitial cells of Cajal in erectile dysfunction |
Q42855656 | Intima‐media thickness of carotid arteries and erectile dysfunction in hemodialysis patients |
Q42961704 | Intracavernosal administration of sodium nitrite as an erectile pharmacotherapy |
Q47257811 | Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Erectile Dysfunction Following Cavernous Nerve Injury in Rats |
Q46392332 | Introduction: Erectile dysfunction and cardiovascular risk factors |
Q90452078 | Investigation of Interactive Activity of Electro-Acupuncture on Pharmacokinetics of Sildenafil and Their Synergistic Effect on Penile Blood Flow in Rats |
Q36253972 | Involvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged Rats |
Q34983511 | Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function |
Q39944599 | Is erectile dysfunction a predictor of cardiovascular events or stroke? A prospective study using a validated questionnaire |
Q35643349 | Is erectile dysfunction a reliable indicator of general health status in men? |
Q73837661 | Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder? |
Q50956102 | Is penile atherosclerosis the link between erectile dysfunction and cardiovascular risk? An autopsy study. |
Q44023185 | Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction? |
Q90576339 | Islet transplantation improved penile tissue fibrosis in a rat model of type 1 diabetes |
Q48519012 | Levels of uric acid in erectile dysfunction of different aetiology. |
Q50125343 | Lipoxin A4 improves erectile dysfunction in rats with type I diabetes by inhibiting oxidative stress and corporal fibrosis |
Q46456930 | Lithium decreased endothelium-mediated, but not nonadrenergic noncholinergic, relaxation of guinea pig corpus cavernosum in vitro: a role for nitrergic system |
Q46930343 | Long-term effect of experimental hypercholesterolemia on cavernosal tissues |
Q48662783 | Long-term outcomes of AMS Spectra® penile prosthesis implantation and satisfaction rates |
Q43938749 | Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction |
Q35007136 | Long-term treatment of clonidine, atenolol, amlodipine and dihydrochlorothiazide, but not enalapril, impairs the sexual function in male spontaneously hypertensive rats |
Q46210987 | Lower Urinary Tract Symptoms, Erectile Dysfunction, and Quality of Life in Poststroke Men: A Controlled Cross-Sectional Study. |
Q33289952 | Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment |
Q37097048 | Lower urinary tract symptoms and sexual dysfunction: a common approach |
Q80295789 | Lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and phosphodiesterase-5 inhibitors |
Q38220350 | Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction? |
Q36575478 | Male erectile dysfunction and microalbuminuria in adult nigerians with essential hypertension |
Q36222944 | Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group |
Q43973084 | Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies |
Q34504227 | Management of erectile dysfunction secondary to treatment for localized prostate cancer |
Q98784275 | Management of male sexual dysfunction after cancer treatment |
Q37811488 | Medical Implications of Erectile Dysfunction |
Q36181835 | Melanocortinergic control of penile erection |
Q86975370 | Men with diabetes may require more aggressive treatment for erectile dysfunction |
Q90071998 | Mesenchymal stem cell-derived exosomes ameliorate erection by reducing oxidative stress damage of corpus cavernosum in a rat model of artery injury |
Q45863380 | Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction |
Q64259298 | Meta-analysis of the efficacy of sexual intercourse for distal ureteric stones |
Q44113058 | Metabolic syndrome: a potential and independent risk factor for erectile dysfunction in the Chinese male population |
Q94453274 | Mitochondrial ATP synthase regulates corpus cavernosum smooth muscle cell function in vivo and in vitro |
Q38118626 | Modulation of soluble guanylate cyclase for the treatment of erectile dysfunction |
Q37127318 | Molecular Yin and Yang of erectile function and dysfunction |
Q33770111 | Molecular targets for diabetes mellitus-associated erectile dysfunction. |
Q36464498 | Mouse model of erectile dysfunction due to diet-induced diabetes mellitus |
Q47220920 | Multicenter pathophysiologic investigation of erectile dysfunction in clinic outpatients in China |
Q37037517 | Multiple sclerosis and sexual dysfunction |
Q47952917 | N-acetylcysteine Ameliorates the Erectile Dysfunction Caused by Chronic Intermittent Hypoxia in Rats: Partly Involvement of Endoplasmic Reticulum Stress |
Q37890138 | Natural therapies used by adult men for the treatment of erectile dysfunction, benign prostatic hyperplasia, and for augmenting exercise performance |
Q34471723 | Neurogenic erectile dysfunction |
Q36824270 | Neurophysiological basis of penile erection |
Q35569842 | New achievements and pharmacotherapeutic approaches to impotence in the elderly |
Q37323289 | New horizons in erectile and endothelial dysfunction research and therapies |
Q44507470 | New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction |
Q35945247 | New treatment options for erectile dysfunction in patients with diabetes mellitus |
Q35563945 | New treatments for erectile dysfunction |
Q37881314 | Newer phosphodiesterase inhibitors: comparison with established agents |
Q44748205 | Nitric oxide release from human corpus cavernosum induced by a purified scorpion toxin. |
Q94400625 | Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea |
Q46697840 | Normal erectile function |
Q73485469 | Normal hemodynamic parameters do not always predict the presence of a rigid erection: a quantitative assessment of functional erectile impairment |
Q37259276 | Obstructive sleep apnea and erectile dysfunction: still a neglected risk factor? |
Q64073912 | Ocimum gratissimum Linn. Leaves reduce the key enzymes activities relevant to erectile dysfunction in isolated penile and testicular tissues of rats |
Q38158658 | Office-based management of impotence and Peyronie's disease |
Q26747277 | Opportunities and challenges for direct C-H functionalization of piperazines |
Q37886052 | Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health |
Q34279534 | Oral drug therapy for erectile dysfunction |
Q80297898 | Oral pharmacotherapy and the contemporary evaluation and management of erectile dysfunction |
Q45148792 | Overactive corpus cavernosum: a novel cause of erectile dysfunction |
Q38232764 | Overview of the relevant literature on the possible role of acupuncture in treating male sexual dysfunction. |
Q34706899 | Oxygen free radicals and the penis |
Q37423701 | Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil |
Q44212094 | Patient satisfaction with testosterone supplementation for the treatment of erectile dysfunction |
Q34553453 | Penile erectile dysfunction after brachial plexus root avulsion injury in rats |
Q46864671 | Penile erection requires association of soluble guanylyl cyclase with endothelial caveolin-1 in rat corpus cavernosum |
Q44309222 | Penile neuronal nitric oxide synthase and its regulatory proteins are present in hypothalamic and spinal cord regions involved in the control of penile erection |
Q47819112 | Penile neurovascular structure revisited: immunohistochemical studies with three-dimensional reconstruction. |
Q37437009 | Penile prosthesis implantation in Chinese patients with severe erectile dysfunction: 10-year experience |
Q37417114 | Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art. |
Q44991133 | Peripheral atherosclerosis in patients with arterial erectile dysfunction |
Q45153798 | Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips. |
Q41897333 | Pharmacological characterization of the relaxant effect induced by adrenomedullin in rat cavernosal smooth muscle |
Q34106728 | Pharmacotherapy for erectile dysfunction |
Q52682027 | Phosphodiesterase (PDE5) inhibition assay for rapid detection of erectile dysfunction drugs and analogs in sexual enhancement products. |
Q34147460 | Phosphodiesterase 5 inhibitors: current status and potential applications |
Q24246544 | Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus |
Q37848067 | Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions |
Q35140096 | Phosphodiesterase type 5 (PDE5) inhibitors |
Q37733556 | Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction |
Q34987811 | Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction |
Q35759044 | Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic, and efficacy profiles. |
Q38630414 | Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons |
Q36206628 | Phosphodiesterase type 5 inhibitors for erectile dysfunction |
Q36993658 | Phosphodiesterase type 5 inhibitors: state of the therapeutic class |
Q36314042 | Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction |
Q33818229 | Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism |
Q36885422 | Physiological regulation of penile arteries and veins |
Q35774866 | Physiology and biochemistry of erections |
Q84970249 | Poly(ADP-Ribose) Polymerase Inhibition Improves Erectile Function in Diabetic Rats |
Q64229328 | Positive Correlation between Left Hemisphere Lesion and Erectile Dysfunction in Post-Stroke Patients |
Q26737724 | Postprostatectomy Erectile Dysfunction: A Review |
Q36572595 | Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor |
Q39636620 | Preclinical evidence for the benefits of penile rehabilitation therapy following nerve-sparing radical prostatectomy. |
Q47905190 | Predictors of erectile function improvement in obstructive sleep apnea patients with long-term CPAP treatment |
Q45017198 | Preserved fertility despite erectile dysfunction in mice lacking the nitric oxide receptor |
Q78829145 | Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men |
Q94922549 | Prevalence of Erectile Dysfunction in Patients with Diabetes Mellitus and Its Association with Body Mass Index and Glycated Hemoglobin in Africa: A Systematic Review and Meta-Analysis |
Q40486793 | Prevalence of erectile dysfunction in a cohort of Italian hypertensive subjects |
Q81004125 | Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients |
Q58860233 | Prevalencia de disfunción eréctil en pacientes con hipertensión arterial |
Q35763083 | Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I. |
Q35763087 | Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II. |
Q36628795 | Priapism: new concepts in the pathophysiology and new treatment strategies |
Q38041867 | Priapism: pathophysiology and the role of the radiologist |
Q64060510 | Prospective Study on Sexual Dysfunction in Male Chinese Liver Transplant Recipients |
Q26746754 | Psychosexual disorders and dermatologists |
Q37793997 | Recent Advances in the Medical and Surgical Treatment of Priapism |
Q42952130 | Reduced Vasoreactivity in Corpus Cavernosum of the Akita Mouse |
Q33506195 | Regulation of peripheral blood flow in complex regional pain syndrome: clinical implication for symptomatic relief and pain management |
Q50084511 | Relationship between oxidative stress and erectile function |
Q46876200 | Relaxant effects of an alkaloid-rich fraction from Aspidosperma ulei root bark on isolated rabbit corpus cavernosum |
Q33650796 | Research in pharmacotherapy for erectile dysfunction |
Q40862954 | Risk factors for erectile dysfunction in patients with cardiovascular disease |
Q35547102 | Role of Caffeine Intake on Erectile Dysfunction in US Men: Results from NHANES 2001-2004 |
Q34020025 | Role of adenosine signaling in penile erection and erectile disorders |
Q37948024 | Role of hydrogen sulfide in the physiology of penile erection |
Q44690668 | Role of some vasoactive mediators in patients with erectile dysfunction: their relationship with angiotensin-converting enzyme and growth hormone |
Q93056029 | S1P1 Gene Transfection Improves Erectile Function in Spontaneously Hypertensive Rats |
Q36792665 | Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects |
Q53346874 | Salt-kneading: alternative sizing of active pharmaceutical ingredients? |
Q47207449 | Screening for erectile dysfunction as part of periodic examination programs--concept and implementation |
Q44363730 | Serum androgen levels in men: impact of health status and age. |
Q53221201 | Severity of erectile dysfunction at presentation: effect of premature ejaculation and low desire. |
Q35419887 | Sexual Dysfunctions of HIV-Positive Men: Associated Factors, Pathophysiology Issues, and Clinical Management |
Q37409488 | Sexual dysfunction in multiple sclerosis |
Q37849338 | Sexual evaluation and treatment of ageing males with haemophilia |
Q36555652 | Sexual function after surgery for prostate or bladder cancer |
Q48248664 | Sexual intercourse as a new option in the medical expulsive therapy of distal ureteral stones in males: a prospective, randomized, controlled study. |
Q83929708 | Shared medical appointments in a pharmacy-based erectile dysfunction clinic |
Q87378922 | Shengjing Capsule Improves Erectile Function Through Regulation of Nitric Oxide-induced Relaxation in Corpus Cavernosum Smooth Muscle in a Castrated Rat Model |
Q36738144 | Short hairpin rna targeting insulin-like growth fator binding protein-3 restores the bioavailability of insulin-like growth factor-1 in diabetic rats |
Q36056143 | Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia. |
Q45989350 | Sildenafil (Viagra) and club drug use in gay and bisexual men: the role of drug combinations and context. |
Q32060378 | Sildenafil citrate: a therapeutic update |
Q36572591 | Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction |
Q45144066 | Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia |
Q37151229 | Small-vessel lower extremity arterial disease and erectile dysfunction: The Rancho Bernardo study |
Q35924319 | Specific aspects of erectile dysfunction in endocrinology |
Q35924328 | Specific aspects of erectile function in urology/andrology |
Q47887533 | Spontaneous Regeneration of Nerve Fiber and Irreversibility of Corporal Smooth Muscle Fibrosis after Cavernous Nerve Crush Injury: Evidence From Serial Transmission Electron Microscopy and Intracavernous Pressure |
Q37078842 | Stem and endothelial progenitor cells in erection biology. |
Q35737480 | Stem cell therapy for erectile dysfunction: a critical review |
Q38148781 | Stem-cell therapy for erectile dysfunction. |
Q44540739 | Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. |
Q42368368 | Surgical Techniques for Managing Post-prostatectomy Erectile Dysfunction |
Q44376216 | Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial |
Q36217695 | Sympathetic Hyperactivity, Increased Tyrosine Hydroxylase and Exaggerated Corpus Cavernosum Relaxations Associated with Oxidative Stress Plays a Major Role in the Penis Dysfunction in Townes Sickle Cell Mouse |
Q43778232 | Synergistic effects of sildenafil on relaxation of rabbit and rat cavernosal smooth muscles when combined with various vasoactive agents |
Q43908604 | Tadalafil and vardenafil. |
Q41978073 | Tadalafil in the treatment of erectile dysfunction |
Q35827477 | Tadalafil pharmacokinetics in healthy subjects |
Q33700805 | Target profiling of a small library of phosphodiesterase 5 (PDE5) inhibitors using chemical proteomics. |
Q41153819 | Testosterone improves erectile function through inhibition of reactive oxygen species generation in castrated rats |
Q37890133 | Testosterone replacement therapy in males with erectile dysfunction |
Q35746088 | Thalamus and penile erection |
Q60045178 | The 100 most influential manuscripts in andrology: a bibliometric analysis |
Q38631968 | The Challenge of Erectile Dysfunction Management in the Young Man. |
Q90520802 | The Combined Use of Stem Cells and Platelet Lysate Plasma for the Treatment of Erectile Dysfunction: A Pilot Study-6 Months Results |
Q39067832 | The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review |
Q33642022 | The Effect of Alcohol Administration on the Corpus Cavernosum. |
Q36039353 | The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction. |
Q41978840 | The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up |
Q36992225 | The GAy MEn Sex StudieS: erectile dysfunction among Belgian gay men |
Q38479677 | The Old Made New: Natural Compounds against Erectile Dysfunction. |
Q36530187 | The application of color Doppler flow imaging in the diagnosis and therapeutic effect evaluation of erectile dysfunction |
Q53229012 | The associations among eNOS G894T gene polymorphism, erectile dysfunction and related risk factors. |
Q73023984 | The clinical evaluation of common sexual concerns |
Q43899123 | The clinical studies of sildenafil for the ageing male |
Q48731350 | The correlation between high sensitivity C-reactive protein and erectile dysfunction patients with hypertension treated with vardenafil |
Q44449452 | The effect of long-term oral tadalafil treatment on corpus cavernosum function in an experimental spinal cord transection rat model |
Q49139040 | The effect of pelvic floor muscle training on sexual function in men with lower urinary tract symptoms after stroke |
Q44306205 | The effect of periodontal treatment in improving erectile dysfunction: a randomized controlled trial |
Q35827206 | The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease. |
Q36255181 | The efficacy and safety of PDE5 inhibitors |
Q47866490 | The efficacy of udenafil in end-stage renal disease patients undergoing hemodialysis |
Q41456612 | The evaluation of sexual dysfunction in male patients with migraine and tension type headache. |
Q35073161 | The false organic-psychogenic distinction and related problems in the classification of erectile dysfunction. |
Q35186022 | The future is today: emerging drugs for the treatment of erectile dysfunction |
Q33244595 | The hypoactive corpora cavernosa with degenerative erectile dysfunction: a new syndrome |
Q43160861 | The impact of irritative lower urinary tract symptoms on erectile dysfunction in aging Taiwanese males. |
Q35993845 | The impact of metabolic syndrome on retinal findings in patients with erectile dysfunction |
Q44695350 | The impact of sildenafil citrate on sexual satisfaction profiles in men with a penile prosthesis in situ |
Q47441673 | The impact of surgery for trochanteric femur fracture on sexuality in men and their female partners |
Q90663802 | The link between periodontitis and erectile dysfunction: a review |
Q35055194 | The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function |
Q45987400 | The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure. |
Q36925283 | The quality of lifestyle and the quality of life |
Q38907130 | The relation between erectile dysfunction and extent of coronary artery disease in the patients with stable coronary artery disease |
Q93053492 | The relationship between erectile dysfunction and the Atherogenic Index of Plasma |
Q37076223 | The relationship between resting heart rate variability and erectile tumescence among men with normal erectile function |
Q34220107 | The relaxation effect and mechanism of action of higenamine in the rat corpus cavernosum |
Q36009229 | The risk of erectile dysfunction in chronic obstructive pulmonary disease: a population-based cohort study in Taiwan |
Q34635467 | The role of melanocortins in body weight regulation: opportunities for the treatment of obesity |
Q74604281 | The role of melanocortins in body weight regulation: opportunities for the treatment of obesity |
Q26823131 | The role of statins in erectile dysfunction: a systematic review and meta-analysis |
Q36268301 | The supraspinal network in the control of erection |
Q36291014 | The therapeutic dilemma: how to use psychotherapy |
Q36255170 | The underlying pathophysiology and causes of erectile dysfunction |
Q44428191 | The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction |
Q41002184 | Thorax Computed Tomography Findings in Patients with Erectile Dysfunction. |
Q36830299 | Tips and tricks on outpatient initiation and uptitration of beta-blockade in heart failure |
Q35688181 | Topical alprostadil cream for the treatment of erectile dysfunction |
Q44244655 | Topical alprostadil cream for the treatment of erectile dysfunction: a combined analysis of the phase II program |
Q36307487 | Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors |
Q36304785 | Treatment for erectile dysfunction based on patient-reported outcomes: to every man the PDE5 inhibitor that he finds superior |
Q36116534 | Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function |
Q46932537 | Treatment options for autonomic neuropathies |
Q40352545 | Tyrosine-612 in PDE5 contributes to higher affinity for vardenafil over sildenafil |
Q26851999 | Udenafil for the treatment of erectile dysfunction |
Q28288359 | Udenafil: efficacy and tolerability in the management of erectile dysfunction |
Q47444641 | Unreliability of the Duplex Scan in Diagnosing Corporeal Venous Occlusive Disease in Young Healthy Men With Erectile Deficiency |
Q44306281 | Urological comorbidities in patients with rheumatoid arthritis : literature review |
Q46407830 | Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy |
Q44889724 | Use of intraurethral alprostadil in patients not responding to sildenafil citrate |
Q38829614 | Usefulness of serum fetuin-A level as a marker of erectile dysfunction |
Q37720731 | Validation of the International Index of Erectile Function (IIFE) for use in Brazil |
Q45185326 | Vardenafil provides reliable efficacy over time in men with erectile dysfunction |
Q35638042 | Vardenafil treatment for erectile dysfunction |
Q35753433 | Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction |
Q35592397 | Vardenafil: a review of its use in erectile dysfunction |
Q51501668 | Vascular risk factors and erectile dysfunction in a cohort of healthy men. |
Q36039557 | Vasoactive pharmacotherapy to cure erectile dysfunction: fact or fiction? |
Q34808639 | Viagra (sildenafil citrate) and ophthalmology |
Q34329737 | What's new in urology |
Q36359845 | Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem |
Q46640327 | Yohimbine enhances the effect of sildenafil on erectile process in rats |
Q80103350 | [Acute myocardial infarction associated to the Sildenafil consumption. A case report and review of the literature] |
Q87333423 | [Conservative therapy of erectile dysfunction] |
Q44267171 | [Erectile dysfunction] |
Q87423281 | [Guidelines-oriented diagnostics of dyslipidemia] |
Q84536917 | [Influence of aging on male sexual health] |
Q87423401 | [Male sexuality in the elderly] |
Q59238926 | ‘Just Take Viagra’: Erectile Insurance, Prophylactic Certainty and Deficit Correction in Gay Men’s Accounts of Sexuopharmaceutical Use |
Search more.